. 2019 Mar 31;2019:4236562. doi: 10.1155/2019/4236562

Table 2.

The percentages of IFN-γ and TNF-α expressing CD56^dim and CD56^bright NK cells in healthy controls (normal) and SLE patients with active and inactive disease.

			IFN-γ (%)	TNF-α (%)
CD56^dim NK cells	Normal	Media	67.7 ± 2.9	73.7 ± 2.5
	Normal	IL-15	73.6±2.9^∗∗	78.5 ± 3.0^∗
	Inactive SLE	Media	69.2 ± 3.8	75.0 ± 3.5
	Inactive SLE	IL-15	77.1±3.8^∗∗	83.2 ± 3.0^∗
	Active SLE	Media	78.5 ± 4.5^✝	46.9 ± 6.6^✝✝,##
	Active SLE	IL-15	84.4±3.9^∗∗ ^,✝	67.7±4.1^∗∗ ^,✝,#
CD56^bright NK cells	Normal	Media	70.3 ± 4.1	73.0 ± 2.7
	Normal	IL-15	80.1±4.0^∗∗	84.1±3.7^∗∗
	Inactive SLE	Media	69.4 ± 6.6	67.0 ± 7.0
	Inactive SLE	IL-15	72.2 ± 8.6	84.0 ± 2.2^∗
	Active SLE	Media	78.0 ± 8.8	73.7 ± 7.6
	Active SLE	IL-15	89.0 ± 5.2^✝,#	81.5 ± 8.1

^∗ p < 0.05 and ^∗∗ p < 0.01 compared to media; ^✝ p < 0.05 and ^✝✝ p < 0.01 compared to normal; ^# p < 0.05 and ^## p < 0.01 compared to inactive SLE.